Skip to main content
. 2017 Nov 14;8(67):111073–111083. doi: 10.18632/oncotarget.22441

Figure 1. Relation between PSA and prostatic SUVmax of 68Ga-PSMA-11 PET/CT and 18FEC PET/CT in patients without metastases (68Ga-PSMA PET/CT: R 0.42, p= 0.082; 18FEC PET/CT: R 0.033; p = 0.875).

Figure 1